WEC
AMPH icon

Winslow Evans & Crocker’s Amphastar Pharmaceuticals AMPH Stock Holding History

Winslow Evans & Crocker’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,758
Closed -$33K – 1126
2018
Q1 		$33K Hold
1,758
– – 0.01% 563
2017
Q4 		$33.8K Hold
1,758
– – 0.01% 564
2017
Q3 		$31.4K Hold
1,758
– – 0.01% 567
2017
Q2 		$31.4K Hold
1,758
– – 0.01% 658
2017
Q1 		$25.5K Hold
1,758
– – 0.01% 688
2016
Q4 		$32.4K Hold
1,758
– – 0.01% 632
2016
Q3 		$33.4K Buy
1,758
+992
+130% +$18K 0.01% 635
2016
Q2 		$12.3K Buy
+766
New +$10.8K ﹤0.01% 819

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Evans & Crocker's AMPH Position: Q2 2018 in Review

Winslow Evans & Crocker sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2018, closing a stake of 1,758 shares — an estimated $33K sold.

Winslow Evans & Crocker first reported a position in AMPH in Q2 2016 and held it in 8 quarters. The position peaked at $33.8K in Q4 2017. 114 funds tracked by Wall St. Rank hold AMPH as of Q2 2018.

  • Winslow Evans & Crocker reported no remaining Amphastar Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Winslow Evans & Crocker sold 1,758 Amphastar Pharmaceuticals shares in Q2 2018, an estimated $33K.
  • Winslow Evans & Crocker first reported a position in Amphastar Pharmaceuticals in Q2 2016 and held it in 8 quarters.
  • Winslow Evans & Crocker's Amphastar Pharmaceuticals position peaked at $33.8K in Q4 2017.
  • 114 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2018.

Based on Winslow Evans & Crocker's 13F filing for Q2 2018, filed 17 Jul 2018.